Tower Research Capital LLC (Trc) Enanta Pharmaceuticals Inc Transaction History
Tower Research Capital LLC (Trc)
- $3.39 Billion
- Q3 2025
A detailed history of Tower Research Capital LLC (Trc) transactions in Enanta Pharmaceuticals Inc stock. As of the latest transaction made, Tower Research Capital LLC (Trc) holds 1,875 shares of ENTA stock, worth $22,612. This represents 0.0% of its overall portfolio holdings.
Number of Shares
1,875
Previous 5,021
62.66%
Holding current value
$22,612
Previous $37,000
40.54%
% of portfolio
0.0%
Previous 0.0%
Shares
28 transactions
Others Institutions Holding ENTA
# of Institutions
128Shares Held
19.4MCall Options Held
290KPut Options Held
61.7K-
Farallon Capital Management LLC San Francisco, CA2.12MShares$25.6 Million0.11% of portfolio
-
Krensavage Asset Management, LLC New York, NY2.11MShares$25.5 Million10.78% of portfolio
-
Janus Henderson Group PLC London, X01.95MShares$23.5 Million0.01% of portfolio
-
Vanguard Group Inc Valley Forge, PA1.94MShares$23.4 Million0.0% of portfolio
-
Black Rock Inc. New York, NY1.85MShares$22.3 Million0.0% of portfolio
About ENANTA PHARMACEUTICALS INC
- Ticker ENTA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 20,724,900
- Market Cap $250M
- Description
- Enanta Pharmaceuticals, Inc., a biotechnology company, discovers and develops small molecule drugs for the treatment of viral infections and liver diseases. Its research and development disease targets include respiratory syncytial virus, SARS-CoV-2, human metapneumovirus, and hepatitis B virus. The company has a collaborative development and li...